Article info
Section 4: Clinical pharmacy services
4CPS-050 Analysis of real-life use of ibrutinib after relapse to conventional chemotherapy in patients with chronic lymphocytic leukaemia
Citation
4CPS-050 Analysis of real-life use of ibrutinib after relapse to conventional chemotherapy in patients with chronic lymphocytic leukaemia
Publication history
- First published March 23, 2023.
Online issue publication
May 02, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists 2023. No commercial re-use. See rights and permissions. Published by BMJ.